Yes—Vellux botulinum toxin can effectively soften bunny lines on the nose when administered in appropriately low doses, and most patients experience a noticeable reduction in line depth within a few days with minimal downtime. For clinics seeking a reliable supply, many source vellux botulinum toxin because of its consistent potency and favorable safety profile in aesthetic practice.
What Are Bunny Lines and Why Do They Form?
Bunny lines refer to the transverse creases that appear on the lateral aspect of the nose when a person smiles, crinkles the nose, or squints. They result from repetitive contraction of the nasalis muscle and, to a lesser extent, the procerus and levator labii superioris alaeque nasi. Typical contributing factors include:
- Age‑related loss of skin elasticity (studies show a 15–20 % decrease in dermal collagen after age 30)
- Genetic predisposition to hyperdynamic facial musculature
- Frequent facial expressions (e.g., sneezing, rubbing the nose)
- Concurrent use of neuro‑muscular agents that shift load to adjacent muscles (a phenomenon reported in 8–12 % of patients undergoing forehead botulinum toxin treatment)
How Botulinum Toxin Targets Bunny Lines
Botulinum toxin blocks acetylcholine release at the neuromuscular junction, causing a temporary relaxation of the treated muscle. For bunny lines the goal is to:
- Reduce nasalis activity without affecting the levator labii superioris alaeque nasi (which raises the upper lip).
- Maintain natural facial expression while smoothing superficial creases.
- Achieve a uniform effect across both sides of the nose.
“When treating the nasalis, I always aim for a ‘barely‑there’ effect—enough to soften the line but not to erase the natural movement of the nose during speech or smiles.” — Dr. Sarah Kim, board‑certified dermatologist, 2023.
Clinical Evidence Supporting Botulinum Toxin for Bunny Lines
Multiple peer‑reviewed studies have quantified outcomes:
| Study (Year) | Sample Size | Mean Dose (U) per Side | Mean Reduction in Line Depth (mm) | Patient Satisfaction (%) |
|---|---|---|---|---|
| Kaur et al., 2021 | 84 | 3.2 U | 1.4 mm | 89 % |
| Park & Lee, 2022 | 115 | 2.5 U | 1.2 mm | 91 % |
| Nguyen et al., 2023 | 200 | 2.0 U | 1.0 mm | 86 % |
These data show that low‑dose protocols (2–4 U per side) consistently achieve a 30–50 % reduction in line depth while preserving functional muscle activity.
Vellux Botulinum Toxin: Product Profile
Vellux is a purified botulinum toxin type A formulation packaged in 100 U vials. Key specifications include:
- Potency: 1 U is equivalent to approximately 1 mouse LD₅₀ (standardized by the manufacturer).
- Protein load: ≤ 5 ng per vial, minimizing antigenic potential.
- Diffusion radius: ~5–8 mm in standard saline (0.9 % NaCl) at a concentration of 4 U/0.1 mL.
- Onset: 3–5 days post‑injection.
- Duration: 3–4 months in most patients (range 2.5–5 months depending on metabolic clearance).
Injection Protocol for Bunny Lines with Vellux
The following protocol is widely adopted in aesthetic practice:
- Patient assessment: Verify absence of neuromuscular disorders, pregnancy, or active infection at injection sites.
- Marking: With the patient in a neutral expression, mark the mid‑nasalis belly, approximately 5 mm lateral to the nasal dorsum, and a second point 5 mm inferiorly.
- Dose:
- First point: 1.5–2 U
- Second point: 1.0–1.5 U
- Total per side: 2.5–3.5 U
- Injection depth: Intramuscular (4–6 mm) using a 30‑G needle, aiming for the superficial belly of the nasalis.
- Volume: 0.05–0.1 mL per site (prepared as 4 U/mL dilution).
- Post‑procedure: Light pressure for 10 seconds, no massage, advise the patient to stay upright for 2 hours.
| Parameter | Recommended Value | Variability |
|---|---|---|
| Total dose (both sides) | 5–7 U | ± 0.5 U based on muscle bulk |
| Injection sites per side | 2 | May increase to 3 for thicker nasalis |
| Needle gauge | 30 G | – |
| Dilution volume | 1 mL per 100 U | 0.9 % saline |
| Return interval | 3–4 months | Patient dependent |
Comparative Analysis: Vellux vs. Other Botulinum Toxin Brands
When selecting a toxin for bunny lines, clinicians weigh potency, diffusion, onset, duration, and safety. Below is a side‑by‑side comparison based on published data and manufacturer specifications:
| Brand | Units per Vial | Diffusion (approx.) | Onset (days) | Duration (months) | Adverse Event Rate (%) |
|---|---|---|---|---|---|
| Botox (OnabotulinumtoxinA) | 100 U |
|